
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
Alexander Mauskop, MD, director of the New York Headache Center, discusses the symptoms and causes of hemiplegic migraines.
In this video, Alexander Mauskop, MD, director of the New York Headache Center, discusses the symptoms and causes of hemiplegic migraines.






